SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-22-025265
Filing Date
2022-09-20
Accepted
2022-09-20 18:08:57
Documents
1
Period of Report
2022-09-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_166371172268717.html 4  
1 FORM 4 wf-form4_166371172268717.xml 4 3505
  Complete submission text file 0001628280-22-025265.txt   5176
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Issuer) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 310 GODDARD SUITE 150 IRVINE CA 92618
Business Address (949) 753-0624
White Lale (Reporting) CIK: 0001635493 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35558 | Film No.: 221254683